Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Nicotinamide Adenine Dinucleotide Market

Nicotinamide Adenine Dinucleotide Market Share

Report ID: GMI5369
Published Date: Sep 2022
Report Format: PDF

Download Free Sample

Nicotinamide Adenine Dinucleotide Market Share

Bontac Bioengineering
Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
F. Hoffmann-La Roche Ltd
HiMedia Laboratories
NutriScience Innovations, LLC
Nutrifoods
Bontac Bio-engineering(shenzhen)co.,ltd
Krackeler Scientific
Shandong Lankang Bio-Technology Co., Ltd.
OYC Americas, Inc.
Xi'an Yinherb Bio-Tech Co., Ltd
Shenzhen Hygieia Biotechnology Co., Ltd
Zhejiang Dazhan Biotechnology Co., Ltd.
Otto Chemie Pvt. Ltd.
Uthever

are some of the key nicotinamide adenine dinucleotide market players. These companies are adopting strategic mergers, collaborations, and acquisitions to expand their customer base and improve their product offerings.

Authors: Kunal Ahuja, Tushar Malkani

Frequently Asked Questions (FAQ) :

Global Market size for Nicotinamide Adenine Dinucleotide was valued at more than USD 488 million in 2021 and is set to progress at around 13% CAGR over the next 8 years.

The anti-aging products application segment is anticipated to expand at 14.5% CAGR through 2030 owing to the rising popularity of skincare and cosmetics products.

The pharmaceutical grade NAD segment is poised to reach a valuation of more than USD 515 million by 2030 as a result of numerous benefits of the product as an anti-depressant, an anti-aging solution, and for improving cell restoration.

Europe market is slated to reach over USD 330 million in revenue by 2030 as a result of the strong presence of pharmaceutical manufacturers that are providing advanced functional beverage products in the region.